Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines

Hepatitis C virus (HCV) infection is a serious health problem leading to cirrhosis, liver failure and hepatocellular carcinoma. The recent introduction of telaprevir, which was approved in November 2011, in combination with peg-interferon and ribavirin is expected to markedly improve the eradication...

Descripción completa

Detalles Bibliográficos
Autores principales: Chayama, Kazuaki, Hayes, C. Nelson, Ohishi, Waka, Kawakami, Yoshiiku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698425/
https://www.ncbi.nlm.nih.gov/pubmed/23188091
http://dx.doi.org/10.1007/s00535-012-0714-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698425/
https://www.ncbi.nlm.nih.gov/pubmed/23188091
http://dx.doi.org/10.1007/s00535-012-0714-9

Ejemplares similares